Finerenone trials for Heart failure

All Finerenone trials · All Heart failure trials

Phase breakdown

Recruiting trials studying Finerenone for Heart failure

• A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
  NCT06024746 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 140 locations
• A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
  NCT06008197 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 356 locations
• A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
  NCT06033950 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 176 locations
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
  NCT06082063 · Phase: Phase 3 · Ages: 40 Years to 90 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study Finerenone for Heart failure?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.